CN112741318A - Cell activation beverage and preparation method thereof - Google Patents
Cell activation beverage and preparation method thereof Download PDFInfo
- Publication number
- CN112741318A CN112741318A CN202110043856.7A CN202110043856A CN112741318A CN 112741318 A CN112741318 A CN 112741318A CN 202110043856 A CN202110043856 A CN 202110043856A CN 112741318 A CN112741318 A CN 112741318A
- Authority
- CN
- China
- Prior art keywords
- beverage
- parts
- cell
- gluconate
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 58
- 230000020411 cell activation Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 15
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 15
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 14
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 14
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 14
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 14
- 150000004676 glycans Chemical class 0.000 claims abstract description 14
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 14
- 239000005017 polysaccharide Substances 0.000 claims abstract description 14
- 244000068988 Glycine max Species 0.000 claims abstract description 13
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 13
- 244000050907 Hedychium coronarium Species 0.000 claims abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 13
- 240000008042 Zea mays Species 0.000 claims abstract description 12
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 12
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 12
- 235000005822 corn Nutrition 0.000 claims abstract description 12
- 238000007789 sealing Methods 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 16
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 10
- 235000011086 calcium lactate Nutrition 0.000 claims description 10
- 239000001527 calcium lactate Substances 0.000 claims description 10
- 229960002401 calcium lactate Drugs 0.000 claims description 10
- 238000011049 filling Methods 0.000 claims description 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 10
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 10
- 235000013997 pineapple juice Nutrition 0.000 claims description 10
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 9
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 235000019164 vitamin B2 Nutrition 0.000 claims description 9
- 239000011716 vitamin B2 Substances 0.000 claims description 9
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 8
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 8
- 229930064664 L-arginine Natural products 0.000 claims description 8
- 235000014852 L-arginine Nutrition 0.000 claims description 8
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 8
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 8
- 229930003471 Vitamin B2 Natural products 0.000 claims description 8
- 229930003268 Vitamin C Natural products 0.000 claims description 8
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 8
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 8
- 235000013734 beta-carotene Nutrition 0.000 claims description 8
- 239000011648 beta-carotene Substances 0.000 claims description 8
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 8
- 229960002747 betacarotene Drugs 0.000 claims description 8
- 235000012754 curcumin Nutrition 0.000 claims description 8
- 239000004148 curcumin Substances 0.000 claims description 8
- 229940109262 curcumin Drugs 0.000 claims description 8
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 8
- 229960000304 folic acid Drugs 0.000 claims description 8
- 235000019152 folic acid Nutrition 0.000 claims description 8
- 239000011724 folic acid Substances 0.000 claims description 8
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 8
- 235000012661 lycopene Nutrition 0.000 claims description 8
- 239000001751 lycopene Substances 0.000 claims description 8
- 229960004999 lycopene Drugs 0.000 claims description 8
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 8
- 229960002477 riboflavin Drugs 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 8
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 8
- 235000019154 vitamin C Nutrition 0.000 claims description 8
- 239000011718 vitamin C Substances 0.000 claims description 8
- 235000011478 zinc gluconate Nutrition 0.000 claims description 8
- 239000011670 zinc gluconate Substances 0.000 claims description 8
- 229960000306 zinc gluconate Drugs 0.000 claims description 8
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 7
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims description 6
- 229940050410 gluconate Drugs 0.000 claims description 6
- 239000001755 magnesium gluconate Substances 0.000 claims description 6
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 6
- 229960003035 magnesium gluconate Drugs 0.000 claims description 6
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 235000013924 ferrous gluconate Nutrition 0.000 claims description 4
- 239000004222 ferrous gluconate Substances 0.000 claims description 4
- 229960001645 ferrous gluconate Drugs 0.000 claims description 4
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 8
- 235000012680 lutein Nutrition 0.000 description 8
- 239000001656 lutein Substances 0.000 description 8
- 229960005375 lutein Drugs 0.000 description 8
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 8
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 8
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 8
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 8
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 7
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 7
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 7
- 229960004544 cortisone Drugs 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 229960003604 testosterone Drugs 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 208000019901 Anxiety disease Diseases 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000002633 protecting effect Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 238000007605 air drying Methods 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 230000000049 anti-anxiety effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960001456 adenosine triphosphate Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000010226 intestinal metabolism Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000006318 protein oxidation Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention relates to the field of beverage preparation, in particular to a cell activation beverage and a preparation method thereof, wherein the cell activation beverage comprises the following components in parts by weight: 20-22 parts of water, 0.1-0.5 part of trehalose, 0.2-1.0 part of beer yeast, 0.0001-0.0003 part of soybean peptide powder, 0.1-0.5 part of mushroom polysaccharide, 0.1-0.5 part of haematococcus pluvialis, 0.1-0.5 part of corn germ powder and 0.1-0.5 part of white ginger.
Description
Technical Field
The invention relates to the field of beverage preparation, in particular to a cell activation beverage and a preparation method thereof.
Background
The drink is liquid food which is produced by taking water as a main raw material, adding various auxiliary ingredients and then adopting various processes and is directly drunk by people. The beverage has the functions of supplementing human body water, and has certain nutritional functions due to the contents of saccharides, fruit acids, milk, various trace inorganic salts, amino acids, proteins, vitamins and the like.
With the rapid development of economy, the living standard of people is greatly improved, the nutrition is excessive, the nutrition is deposited in the body for a long time, meanwhile, with the acceleration of working rhythm and the increase of living pressure, the human body is in a state of tension and fatigue, the human body is inexhaustible to collect the essence for a long time, and the body is always in a sub-health state.
Disclosure of Invention
Therefore, it is desirable to provide a cell activation beverage and a preparation method thereof, which can effectively improve the cell activity of human body and relieve anxiety state of people.
In order to achieve the purpose, the invention provides a cell activation drink which comprises the following components in parts by weight:
20-22 parts of water, 0.1-0.5 part of trehalose, 0.2-1.0 part of beer yeast, 0.0001-0.0003 part of soybean peptide powder, 0.1-0.5 part of mushroom polysaccharide, 0.1-0.5 part of haematococcus pluvialis, 0.1-0.5 part of corn germ powder and 0.1-0.5 part of white ginger.
Further, the composition comprises the following components in parts by weight:
21.5686 parts of water, 0.3 part of trehalose, 0.5 part of beer yeast, 0.0001 part of soybean peptide powder, 0.3 part of mushroom polysaccharide, 0.3 part of haematococcus pluvialis, 0.2 part of corn germ powder and 0.2 part of white ginger.
Further, the composition also comprises the following components in parts by weight: 1-5 parts of pineapple juice powder, 1-5 parts of fructo-oligosaccharide, 0.1-0.5 part of calcium lactate and 0.001-0.005 part of gluconate. The taste of the beverage is improved, and meanwhile, the beverage can play a role in stabilizing each component and improving the stability of each component.
Further, the composition also comprises the following components in parts by weight: 2 parts of pineapple juice powder, 2 parts of fructo-oligosaccharide, 0.2 part of calcium lactate and 0.003 part of gluconate.
Further, the gluconate is one or more of zinc gluconate, magnesium gluconate and ferrous gluconate.
Further, the composition also comprises the following components in parts by weight:
0.0001-0.0003 part of phosphatidylserine, 0.0001-0.0003 part of vitamin B2, 0.0001-0.0003 part of vitamin C, 0.0001-0.0003 part of curcumin, 0.0001-0.0005 part of lycopene, 0.0001-0.0003 part of folic acid, 0.0001-0.0005 part of beta-carotene, 0.0001-0.0005 part of gamma-aminobutyric acid, 0.0001-0.0005 part of taurine and 0.0001-0.0005 part of L-arginine. The components are all used as trace elements to be filled into the formula of the drink to supplement the nutrient components of the drink.
A preparation method of a cell activation drink comprises the following steps:
(1) weighing the components in proportion;
(2) weighing the components, mixing and stirring to form a beverage crude liquid;
(3) heating the beverage crude liquid to 90-100 deg.C under stirring, and maintaining the temperature for 5-10min to obtain beverage liquid;
(4) filling and sealing the beverage liquid by using a filling and sealing machine to obtain a packaged beverage;
(5) and sterilizing, cooling and drying the packaged beverage in sequence to obtain a finished product package.
Further, in the step (2), the stirring time is 20-30min, and the stirring speed is 100-.
Further, the transverse sealing temperature of the can package in the step (4) is 120-.
Further, in the step (5), the sterilization temperature is 80-85 ℃, and the sterilization time is 10 min.
The pharmacological action of the main components in the formula of the invention is as follows:
the white ginger contains natural vitamin E, is tens of times of synthetic E, can resist bacteria and aging, is helpful for the normal function of an immune system, can improve peripheral circulation, enables peripheral capillaries to be unobstructed, quickly delivers nutrients to cells of the whole body, can inhibit the transfer of melanin from black cells to protein cells, reduces pigmentation, accelerates the metabolism of the stratum corneum of the skin and reduces the generation of wrinkles.
Trehalose, trehalose can form a unique protective film on the cell surface under severe environmental conditions such as high temperature, high cold, high osmotic pressure, drying and dehydration, and effectively protects protein molecules from being inactivated, thereby maintaining the life process and biological characteristics of a living body.
Phosphatidylserine has the functions of improving nerve cell function, regulating the conduction of nerve pulse and enhancing the memory function of brain, and can rapidly enter the brain through a blood brain barrier after being absorbed due to strong lipophilicity, thereby playing the roles of relieving blood vessel smooth muscle cells and increasing the blood supply of the brain.
Beer yeast has high content of vitamins and proteins, and can be used as edible, medicinal and feed yeast, and also can extract cytochrome C, nucleic acid, glutathione, prothrombin, coenzyme A, adenosine triphosphate, etc. from it.
The soybean peptide powder is rich in nutrition and easy to absorb, and has the effects of resisting hypertension, reducing cholesterol, resisting thrombosis, improving lipid metabolism, preventing arteriosclerosis, enhancing physical strength and muscle strength of a human body, promoting recovery of myoerythrocytes, eliminating fatigue, promoting absorption of calcium, phosphorus and other trace elements, and improving the strength of bones; it also has effects in promoting brain development, improving memory, enhancing activity of phagocyte and B cell, enhancing immunity, resisting cancer and aging, protecting epidermal cell, preventing melanin pigmentation, eliminating oxidative free radical, and clearing blood; can promote cell reproduction, protect liver, prevent liver cirrhosis, and promote liver function recovery, and has medical and prophylactic effects for diabetes patients; and can be used for preventing senile dementia and cholelithiasis.
The mushroom polysaccharide can enhance the function of T lymphocytes, thereby improving the immunity of the body against various diseases; has obvious functions of relieving cough and thinning sputum; can keep water balance in intestine, absorb residual cholesterol and sugar, and discharge them out of body, and is very beneficial for preventing constipation, intestinal cancer, arteriosclerosis, diabetes, etc.; the mushroom polysaccharide can also be used for treating leukopenia and digestive tract disorder; has certain auxiliary effects of promoting appetite, recovering brain function and promoting milk secretion.
Haematococcus pluvialis can well enhance the strength and endurance of human muscles and relieve sports fatigue. Has obvious effect on enhancing cell regeneration capacity and protecting human cells and DNA health, and can resist aging, protect eyes, protect skin, rebuild collagen and shape skin elasticity. Haematococcus pluvialis can maximally avoid the low-density protein oxidation, thereby helping to achieve the effects of reducing plaque formation and recovering blood vessel elasticity and maintaining the health of a cardiovascular system.
The corn germ powder has the anti-aging effect, contains the vitamins A and E and the glutamine, also contains the lysine and the trace element selenium, has the anti-oxidation effect, is beneficial to preventing aging, is rich in the vitamins B1, B2 and B6, and has the effects of protecting and beautifying the skin. Has effects in promoting gastrointestinal peristalsis and preventing constipation; can promote intestinal metabolism and accelerate toxin discharge. It has effects in softening blood vessel, reducing cholesterol, and preventing arteriosclerosis. Has eyesight protecting effect, and is an excellent supplement food for resisting eye aging
The technical scheme has the following beneficial effects:
in the invention, the trehalose, the beer yeast, the mushroom polysaccharide and the haematococcus pluvialis are used together with the beer yeast, the soybean peptide powder and the white ginger, the compatibility is scientific and reasonable, the synergistic effect is obvious, complete nutrient components can be provided for a human body, the concentrations of testosterone and lutein in human blood can be improved, human cells are activated, the metabolism of human tissue cells is promoted, and further the growth and development of the human body are promoted.
The components of the invention have simple and reasonable proportion, the effects of the raw materials supplement each other, the finished product is in the form of a beverage product, and the human body can realize the function of antianxiety by drinking the beverage in daily life.
Drawings
FIG. 1 is a graph showing the regulation ability of the cell-activated drink prepared in examples 1, 2 and 3 to testosterone.
FIG. 2 shows the ability of the cell-activated beverages prepared in examples 1, 2 and 3 to regulate lutein.
FIG. 3 shows the ability of the cell activation drinks prepared in examples 1, 2 and 3 to regulate cortisone.
FIG. 4 is a graph of the change in pressure perception scale scores of the inactivated beverage prepared in example 1 according to the detailed description of the present invention and a blank experiment.
FIG. 5 is a graph of mental health scale score changes for the activated cell beverage prepared in example 1 and a blank experiment according to an embodiment.
FIG. 6 is a graph of the change in the melancholy-anxiety-stress scale score for the activated cell beverage prepared in example 1 and a blank experiment according to one embodiment
Detailed Description
To explain technical contents, structural features, and objects and effects of the technical solutions in detail, the following detailed description is given with reference to the accompanying drawings in conjunction with the embodiments.
Example 1
A cell activation drink comprises the following components in parts by weight:
21.5686 parts of water, 0.3 part of trehalose, 0.5 part of beer yeast, 0.0001 part of soybean peptide powder, 0.3 part of mushroom polysaccharide, 0.3 part of haematococcus pluvialis, 0.2 part of corn germ powder, 0.2 part of white ginger, 2 parts of pineapple juice powder, 2 parts of fructo-oligosaccharide, 0.2 part of calcium lactate, 0.002 part of zinc gluconate, 0.001 part of magnesium gluconate, 0.0002 part of phosphatidylserine, 0.0002 part of vitamin B2, 0.0002 part of vitamin C, 0.0002 part of curcumin, 0.0002 part of lycopene, 0.0003 part of folic acid, 0.0003 part of beta-carotene, 0.0003 part of gamma-aminobutyric acid, 0.0003 part of taurine and 0.0003 part of L-arginine.
The preparation method of the beverage in the embodiment comprises the following steps:
(1) weighing trehalose, beer yeast, soybean peptide powder, mushroom polysaccharide, haematococcus pluvialis, corn germ powder, white ginger, pineapple juice powder, fructo-oligosaccharide, calcium lactate, zinc gluconate, magnesium gluconate, phosphatidylserine, vitamin B2, vitamin C, curcumin, lycopene, folic acid, beta-carotene, gamma-aminobutyric acid, taurine, L-arginine and water in proportion;
(2) adding the rest components into water, mixing and stirring to obtain beverage crude liquid, wherein the stirring time is 25min, and the stirring speed is 150 r/min;
(3) heating the crude beverage solution to 95 deg.C under stirring, and maintaining the temperature for 7min to obtain beverage solution;
(4) filling and sealing the beverage liquid by using a filling and sealing machine to obtain a packaged beverage, wherein the transverse sealing temperature is 150 ℃, the longitudinal sealing temperature is 160 ℃, and the sealing speed is 40 bags/min;
(5) sterilizing the packaged beverage at 80 deg.C for 10min, sequentially cooling, air drying, and packaging to obtain final product.
Example 2
A cell activation drink comprises the following components in parts by weight:
20 parts of water, 0.1 part of trehalose, 0.2 part of beer yeast, 0.0001 part of soybean peptide powder, 0.1 part of mushroom polysaccharide, 0.1 part of haematococcus pluvialis, 0.1 part of corn germ powder, 0.1 part of white ginger, 1 part of pineapple juice powder, 1 part of fructo-oligosaccharide, 0.1 part of calcium lactate, 0.001 part of zinc gluconate, 0.0001 part of phosphatidylserine, 0.0001 part of vitamin B2, 0.0001 part of vitamin C, 0.0001 part of curcumin, 0.0001 part of lycopene, 0.0001 part of folic acid, 0.0001 part of beta-carotene, 0.0001 part of gamma-aminobutyric acid, 0.0001 part of taurine and 0.0001 part of L-arginine.
The preparation method of the beverage in the embodiment comprises the following steps:
(1) weighing trehalose, beer yeast, soybean peptide powder, mushroom polysaccharide, haematococcus pluvialis, corn germ powder, white ginger, pineapple juice powder, fructo-oligosaccharide, calcium lactate, zinc gluconate, phosphatidylserine, vitamin B2, vitamin C, curcumin, lycopene, folic acid, beta-carotene, gamma-aminobutyric acid, taurine, L-arginine and water in proportion;
(2) adding the rest components into water, mixing and stirring to obtain beverage crude liquid, wherein the stirring time is 20min, and the stirring speed is 200 r/min;
(3) heating the crude beverage solution to 90 deg.C under stirring, and maintaining the temperature for 10min to obtain beverage solution;
(4) filling and sealing the beverage liquid by using a filling and sealing machine to obtain a packaged beverage, wherein the transverse sealing temperature is 120 ℃, the longitudinal sealing temperature is 100 ℃, and the sealing speed is 50 bags/min;
(5) sterilizing the packaged beverage at 85 deg.C for 5min, sequentially cooling, air drying, and packaging to obtain final product.
Example 3
A cell activation drink comprises the following components in parts by weight:
22 parts of water, 0.5 part of trehalose, 1.0 part of beer yeast, 0.0003 part of soybean peptide powder, 0.5 part of mushroom polysaccharide, 0.5 part of haematococcus pluvialis, 0.5 part of corn germ powder, 0.5 part of white ginger, 5 parts of pineapple juice powder, 5 parts of fructo-oligosaccharide, 0.5 part of calcium lactate, 0.003 part of zinc gluconate, 0.001 part of magnesium gluconate, 0.001 part of ferrous gluconate, 0.0003 part of phosphatidylserine, 0.0003 part of vitamin B2, 0.0003 part of vitamin C, 0.0003 part of curcumin, 0.0005 part of lycopene, 0.0003 part of folic acid, 0.0005 part of beta-carotene, 0.0005 part of gamma-aminobutyric acid, 0.0005 part of taurine and 0.0005 part of L-arginine.
The preparation method of the beverage in the embodiment comprises the following steps:
(1) weighing trehalose, beer yeast, soybean peptide powder, mushroom polysaccharide, haematococcus pluvialis, corn germ powder, white ginger, pineapple juice powder, fructo-oligosaccharide, calcium lactate, zinc gluconate, magnesium gluconate, ferrous gluconate, phosphatidylserine, vitamin B2, vitamin C, curcumin, lycopene, folic acid, beta-carotene, gamma-aminobutyric acid, taurine, L-arginine and water in proportion;
(2) adding the rest components into water, mixing and stirring to obtain beverage crude liquid, wherein the stirring time is 30min, and the stirring speed is 100 r/min;
(3) heating the crude beverage solution to 100 deg.C under stirring, and maintaining the temperature for 5min to obtain beverage solution;
(4) filling and sealing the beverage liquid by using a filling and sealing machine to obtain a packaged beverage, wherein the transverse sealing temperature is 170 ℃, the longitudinal sealing temperature is 210 ℃, and the sealing speed is 50 bags/min;
(5) sterilizing the packaged beverage at 80 deg.C for 20min, sequentially cooling, air drying, and packaging to obtain final product package.
The drink prepared in the examples 1, 2 and 3 is used as an experimental group, a blank experiment is used as a control group, the regulation capability of the drink on the concentrations of testosterone and lutein in a human body is tested, each group of experiments has 20-25 volunteers, the drinking frequency of the experimental group is 30 ml/time, 3 times/day and 90 days, the concentrations of testosterone and lutein on the 0 th day and the 90 th day are respectively tested, and the final result is averaged and is shown in the figure 1-2.
As can be seen from FIGS. 1-2, the beverage of the present invention can increase the concentration of testosterone and lutein in human body, wherein the concentration of testosterone and lutein increases from 4.5ng/mL to 6.0ng/mL by 33.33% and the concentration of lutein increases from 4.1mIU/mL to 5.2mIU/mL by 26.83% using the experimental group of the beverage of example 1, and the increase of the concentration of testosterone and lutein can contribute to the metabolism, growth and development of human body.
The drinks prepared in examples 1, 2 and 3 were used as experimental groups, blank experiments were used as control groups, the drink was tested for its ability to regulate cortisone in humans, each group had 20-25 volunteers, the frequency of drinking drinks was 30 ml/time and 3 times/day for the experimental group, and the cortisone concentrations were measured on day 0 and day 60 respectively for a period of 60 days, and the final results were averaged as shown in fig. 3.
As can be seen from FIG. 3, the drink of the present invention can reduce the cortisone concentration in human body, wherein the cortisone concentration is reduced from 15.6 μ g/dL to 10.3 μ g/dL in the experimental group using the drink of example 1, and the cortisone in human body is easy to rise in stress and anxiety environment, so it is presumed that the drink of the present invention can effectively reduce the stress and anxiety feeling of human body.
The drink of example 1 was used as an experimental group, blank experiments were used as a control group, each group of experiments had 20 to 25 volunteers, the frequency of drinking the drink in the experimental group was 30 ml/time and 3 times/day, and the volunteers on day 0 and day 60 were tested for a period of 60 days for a pressure perception scale, a mental health scale and a depression-anxiety-pressure scale, respectively, and the experimental results are shown in fig. 4 to 6.
As can be seen from fig. 4-6, the stress scores of the volunteers in the experimental group of example 1 were greatly decreased before and after, thereby demonstrating that the beverage of the present invention can effectively reduce the concentration of cortisone in the blood of human body, thereby relieving stress and achieving the effect of anti-anxiety.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or terminal that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or terminal. Without further limitation, an element defined by the phrases "comprising … …" or "comprising … …" does not exclude the presence of additional elements in a process, method, article, or terminal that comprises the element. Further, herein, "greater than," "less than," "more than," and the like are understood to exclude the present numbers; the terms "above", "below", "within" and the like are to be understood as including the number.
Although the embodiments have been described, once the basic inventive concept is obtained, other variations and modifications of these embodiments can be made by those skilled in the art, so that the above embodiments are only examples of the present invention, and not intended to limit the scope of the present invention, and all equivalent structures or equivalent processes using the contents of the present specification and drawings, or any other related technical fields, which are directly or indirectly applied thereto, are included in the scope of the present invention.
Claims (10)
1. A cell activation drink is characterized by comprising the following components in parts by weight:
20-22 parts of water, 0.1-0.5 part of trehalose, 0.2-1.0 part of beer yeast, 0.0001-0.0003 part of soybean peptide powder, 0.1-0.5 part of mushroom polysaccharide, 0.1-0.5 part of haematococcus pluvialis, 0.1-0.5 part of corn germ powder and 0.1-0.5 part of white ginger.
2. The cell-activated beverage according to claim 1, comprising the following components in parts by weight:
21.5686 parts of water, 0.3 part of trehalose, 0.5 part of beer yeast, 0.0001 part of soybean peptide powder, 0.3 part of mushroom polysaccharide, 0.3 part of haematococcus pluvialis, 0.2 part of corn germ powder and 0.2 part of white ginger.
3. The cell-activated beverage according to claim 1, further comprising the following components in parts by weight: 1-5 parts of pineapple juice powder, 1-5 parts of fructo-oligosaccharide, 0.1-0.5 part of calcium lactate and 0.001-0.005 part of gluconate.
4. The cell-activated beverage according to claim 3, further comprising the following components in parts by weight: 2 parts of pineapple juice powder, 2 parts of fructo-oligosaccharide, 0.2 part of calcium lactate and 0.003 part of gluconate.
5. The cell-activated beverage according to claim 3 wherein the gluconate is one or more of zinc gluconate, magnesium gluconate and ferrous gluconate.
6. The cell-activated beverage according to claim 1, further comprising the following components in parts by weight:
0.0001-0.0003 part of phosphatidylserine, 0.0001-0.0003 part of vitamin B2, 0.0001-0.0003 part of vitamin C, 0.0001-0.0003 part of curcumin, 0.0001-0.0005 part of lycopene, 0.0001-0.0003 part of folic acid, 0.0001-0.0005 part of beta-carotene, 0.0001-0.0005 part of gamma-aminobutyric acid, 0.0001-0.0005 part of taurine and 0.0001-0.0005 part of L-arginine.
7. A preparation method of a cell activation drink is characterized by comprising the following steps:
(1) weighing the components of the cell activation drink according to any one of claims 1 to 6 in proportion;
(2) weighing the components, mixing and stirring to form a beverage crude liquid;
(3) heating the beverage crude liquid to 90-100 deg.C under stirring, and maintaining the temperature for 5-10min to obtain beverage liquid;
(4) filling and sealing the beverage liquid by using a filling and sealing machine to obtain a packaged beverage;
(5) and sterilizing, cooling and drying the packaged beverage in sequence to obtain a finished product.
8. The method as claimed in claim 7, wherein in the step (2), the stirring time is 20-30min, and the stirring speed is 100-200 r/min.
9. The method as claimed in claim 7, wherein in the step (4), the transverse sealing temperature is 170 ℃, the longitudinal sealing temperature is 100-210 ℃, and the sealing speed is 30-50 packets/min.
10. The method according to claim 7, wherein in the step (5), the sterilization temperature is 80-85 ℃ and the sterilization time is 5-20 min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110043856.7A CN112741318A (en) | 2021-01-13 | 2021-01-13 | Cell activation beverage and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110043856.7A CN112741318A (en) | 2021-01-13 | 2021-01-13 | Cell activation beverage and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112741318A true CN112741318A (en) | 2021-05-04 |
Family
ID=75651210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110043856.7A Pending CN112741318A (en) | 2021-01-13 | 2021-01-13 | Cell activation beverage and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112741318A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113678973A (en) * | 2021-08-06 | 2021-11-23 | 微肽科技(海南)有限公司 | Noni enzyme collagen peptide composite beverage and preparation method thereof |
CN113907362A (en) * | 2021-10-13 | 2022-01-11 | 李毅智 | Dietary therapy formula for activating cell energy, repairing damaged cells and strengthening stem cell treatment potential and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040101934A1 (en) * | 2001-02-27 | 2004-05-27 | Choe Yun Seok | Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and preparing process thereof |
CN105053866A (en) * | 2015-08-10 | 2015-11-18 | 上海量健企业管理咨询服务有限公司 | Intestine moistening and bowel relaxing compound germ meal and preparation method thereof |
CN105285952A (en) * | 2015-10-29 | 2016-02-03 | 华海正元(福建)生物科技有限公司 | Meal replacement powder with balanced nutrients and preparation method of meal replacement powder |
CN109717343A (en) * | 2019-02-20 | 2019-05-07 | 西安源森生物科技有限公司 | It is a kind of to have effects that improve the solid beverage and preparation method thereof of oxidative stress |
CN110537649A (en) * | 2019-10-13 | 2019-12-06 | 无锡嬿侣生物科技有限公司 | Health beverage containing collagen |
CN110584116A (en) * | 2019-09-18 | 2019-12-20 | 孙启城 | A food containing Haematococcus pluvialis and trehalose |
CN111480850A (en) * | 2020-05-19 | 2020-08-04 | 昆明白鸥微藻技术有限公司 | Haematococcus pluvialis and collagen protein beverage |
CN111743144A (en) * | 2020-06-18 | 2020-10-09 | 颜如玉医药科技有限公司 | Double-mushroom composite peptide composition and preparation method and application thereof |
-
2021
- 2021-01-13 CN CN202110043856.7A patent/CN112741318A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040101934A1 (en) * | 2001-02-27 | 2004-05-27 | Choe Yun Seok | Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and preparing process thereof |
CN105053866A (en) * | 2015-08-10 | 2015-11-18 | 上海量健企业管理咨询服务有限公司 | Intestine moistening and bowel relaxing compound germ meal and preparation method thereof |
CN105285952A (en) * | 2015-10-29 | 2016-02-03 | 华海正元(福建)生物科技有限公司 | Meal replacement powder with balanced nutrients and preparation method of meal replacement powder |
CN109717343A (en) * | 2019-02-20 | 2019-05-07 | 西安源森生物科技有限公司 | It is a kind of to have effects that improve the solid beverage and preparation method thereof of oxidative stress |
CN110584116A (en) * | 2019-09-18 | 2019-12-20 | 孙启城 | A food containing Haematococcus pluvialis and trehalose |
CN110537649A (en) * | 2019-10-13 | 2019-12-06 | 无锡嬿侣生物科技有限公司 | Health beverage containing collagen |
CN111480850A (en) * | 2020-05-19 | 2020-08-04 | 昆明白鸥微藻技术有限公司 | Haematococcus pluvialis and collagen protein beverage |
CN111743144A (en) * | 2020-06-18 | 2020-10-09 | 颜如玉医药科技有限公司 | Double-mushroom composite peptide composition and preparation method and application thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113678973A (en) * | 2021-08-06 | 2021-11-23 | 微肽科技(海南)有限公司 | Noni enzyme collagen peptide composite beverage and preparation method thereof |
CN113907362A (en) * | 2021-10-13 | 2022-01-11 | 李毅智 | Dietary therapy formula for activating cell energy, repairing damaged cells and strengthening stem cell treatment potential and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100358427C (en) | Milk solid food or beverage with effects of resisting oxidation, regulating blood, protecting heart and delaying aging | |
CN108967800A (en) | A kind of functional solid beverage and preparation method thereof | |
CN112741318A (en) | Cell activation beverage and preparation method thereof | |
CN108782874A (en) | A kind of selenium-rich black tea drinks | |
JP6435079B1 (en) | Composition for promoting an increase in the amount of BDNF in the body | |
CN107232471A (en) | A kind of nutrient solid beverage | |
CN107183457A (en) | A kind of probiotic fruit juice beverage and preparation method thereof | |
CN113142437A (en) | Sialic acid composite fruit and vegetable juice beverage and preparation method thereof | |
CN113615783A (en) | Yak collagen peptide sports drink | |
CN103609701A (en) | Yoghourt suitable for patients with fatty liver to drink and processing process | |
CN104450357A (en) | Method for brewing red date wine | |
CN113080344A (en) | Collagen enzyme fruity beverage for promoting slimming and skin beautifying and preparation method thereof | |
CN102078016A (en) | Glossy ganoderma and Chinese yam beverage and preparation method thereof | |
CN110547447A (en) | Royal jelly collagen fruit enzyme and preparation method thereof | |
CN105586217A (en) | Osmanthus fragrans fruit wine and preparation method thereof | |
CN112753768A (en) | Plant double-protein fermented flavored yogurt and preparation method thereof | |
CN112772809A (en) | Special beverage for sports training and preparation method thereof | |
CN104287044A (en) | Kiwi fruit and red tea fungus drink | |
JP2005312424A (en) | Method for producing fermented product using kefir grain, and fermented product obtained by the same | |
CN108450721A (en) | A kind of apple shaddock vinegar beverage and preparation method thereof | |
CN107439866A (en) | Matrimony vine chickpea plant nutrients beverage and its preparation technology | |
CN105558045A (en) | Pasteurized modified milk and preparation method thereof | |
CN107874245A (en) | Lactose intolerance can be avoided and the nutrient powder of nutrition is provided for lactose intolerance crowd | |
CN108125081A (en) | A kind of fragrant and sweet type beverage made of fruits or vegetables of passion fruit and preparation process | |
CN1985664A (en) | Double egg white food for teenage and its making process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210504 |
|
RJ01 | Rejection of invention patent application after publication |